IQVIA Holdings (IQV) Q1 2026 earnings snapshot

IQVIA Holdings (IQV) opened 2026 with Q1 revenue of about US$4.2b and basic EPS of US$1.63, setting the tone for how its earnings profile is evolving after a year in which trailing 12 month EPS came in at US$8.14 on revenue of about US$16.6b. Over the last five reported quarters, the company has seen quarterly revenue move from US$3.8b in Q1 2025 to US$4.2b in Q1 2026, while basic EPS across those prints has ranged between US$1.42 and US$3.02, giving investors a clear read on how profit per share tracks the top line. With a trailing net profit margin of 8.3% against 8.6% a year ago, the latest results keep the focus firmly on how efficiently IQVIA is converting a growing revenue base into consistent earnings.

See our full analysis for IQVIA Holdings.

With the headline numbers in place, the next step is to set these results against the most common market narratives around IQVIA to see which stories the data supports and which ones start to look less convincing.

Backlog and EPS trends behind the 3.8% earnings growth

• Over the last 12 months IQVIA generated basic EPS of US$8.14 on US$16.6b of revenue and net income of US$1.4b, compared with quarterly EPS that has moved between about US$1.42 and US$3.02 over the last six reported quarters.
• Bulls argue that earnings growth of 3.8% over the past year, together with forecasts of about 13.7% annual EPS growth, reflects the benefit of IQVIA's record US$32b R&DS backlog and expanding real world data offerings. However, the current 8.3% net margin and the quarterly EPS range show that translating backlog and data assets into consistently higher per share profits is still a work in progress.
  • Supportive for the bullish view, trailing revenue of US$16.6b is higher than any single quarter in the data and aligns with the idea of a sizeable contracted book of work feeding through to the income statement.
  • Challenging that same view, net margin has edged from 8.6% to 8.3%, which means a larger revenue base has not yet produced the margin expansion that bullish expectations are built around.

Bulls point to AI, real world data, and that US$32b backlog as reasons this 3.8% earnings growth could be just the start. The actual 8.3% margin and uneven quarterly EPS keep the debate open for long term holders weighing how much of that story is already in the price. 🐂 IQVIA Holdings Bull Case

Debt coverage risk vs 8.3% net margin

• IQVIA's trailing net profit margin sits at 8.3% on US$16.6b of revenue and US$1.4b of net income, and the main flagged risk is that debt is not well covered by operating cash flow over the same period.
• Bears highlight that high leverage and weak operating cash flow coverage of debt could limit financial flexibility, arguing that even with an 8.3% margin and earnings growth of 3.8% over the last year, interest costs and refinancing needs could soak up a meaningful share of those profits.
  • This concern is backed by the data point that debt is not well covered by operating cash flow, which stands in contrast to the otherwise solid net income figure of US$1.4b.
  • At the same time, the fact that margins have only slipped from 8.6% to 8.3% suggests profitability has not yet been hit hard. The key question for more cautious investors is how long that balance between earnings and balance sheet pressure can be maintained.

Skeptics point to that combination of 8.3% net margin and weak cash flow coverage as a reason to keep a close eye on leverage if growth or pricing were to soften. 🐻 IQVIA Holdings Bear Case

P/E of 21.3x and DCF fair value tension

• IQVIA trades on a trailing P/E of 21.3x compared with a Global Life Sciences industry average of 37.3x and a peer average of 43.4x, while a DCF fair value of US$333.49 sits well above the current share price of US$176.47.
• Consensus narrative points to this gap as one of the main tension points, with a single analyst price target of US$229.35 and DCF fair value both sitting above the market price. However, the 5.9% revenue growth rate over the last year is below the 11.3% US market rate and net margin has slipped to 8.3%, which may explain why the market is not assigning industry level multiples despite the valuation metrics that suggest upside.
  • The discount to industry and peer P/E multiples is consistent with investors focusing on slower revenue growth and modest margin slippage rather than just headline earnings growth of 3.8%.
  • At the same time, the combination of US$8.14 in trailing EPS and the P/E of 21.3x is what underpins the DCF fair value and price target gap, so any change in earnings durability or leverage risk could quickly shift how that valuation spread is viewed.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for IQVIA Holdings on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Mixed signals on IQVIA's growth, debt, and valuation can leave the picture feeling unresolved, so move quickly to weigh both sides of the story using the full breakdown of 5 key rewards and 1 important warning sign

See What Else Is Out There

IQVIA's modest 3.8% earnings growth, soft 5.9% revenue growth, slipping 8.3% net margin and weak debt coverage highlight both profit and balance sheet pressure.

If that mix of leverage risk and only modest earnings progress gives you pause, you may want to compare it with companies screened for stronger fundamentals using the solid balance sheet and fundamentals stocks screener (45 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.